Prognosis in occult cancer of the prostate
Termansen, N.B.; Thybo, E.
Ugeskrift for Laeger 132(45): 2127-2129
1970
ISSN/ISBN: 0041-5782 PMID: 5480576 Document Number: 26417
Document emailed within 1 workday
Related Documents
Murase, T.; Kuriyama, M.; Maeda, S.; Ando, Y.; Itoh, H.; Watanabe, H. 1996: Prognosis in stage a prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 42(9): 639-643Lopez, J.G.; Perrin, P. 1999: Cancer of the prostate. Diagnosis, prognosis, principles of treatment La Revue du Praticien 49(3): 297-301
Harada, M.; Mostofi, F.K.; Corle, D.K.; Byar, D.P.; Trump, B.F. 1977: Preliminary studies of histologic prognosis in cancer of the prostate Cancer Treatment Reports 61(2): 223-225
Colombel, M.; Mallame, W.; Abbou, C.C. 1997: Influence of urological complications on the prognosis of prostate cancer European Urology 31(Suppl): 21-24
Capoun, O.; Soukup, V.; Mikulová, V.; Jančíková, M.ét.; Honová, H.; Kološtová, K.ín.; Zima, T.áš; Hanuš, T.áš 2014: Circulating tumor cells and prostate cancer prognosis Casopis Lekaru Ceskych 153(2): 72-77
Akimoto, S.; Masai, M.; Isaka, S.; Shimazaki, J.; Murakami, S.; Igarashi, T. 1990: Prognosis of the patients with prostate cancer clinically confined within the pelvis Hinyokika Kiyo. Acta Urologica Japonica 36(9): 1039-1045
Viollet, G.; Robin, M.; Colombeau, P.; Ciblac, G. 1977: Apropos of diagnosis, prognosis and hormonal treatment of cancer of the prostate Journal d'Urologie et de Nephrologie 83(10-11): 896-900
Umbas, R.; Isaacs, W.B.; Bringuier, P.P.; Schaafsma, H.E.; Karthaus, H.F.; Oosterhof, G.O.; Debruyne, F.M.; Schalken, J.A. 1994: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer Cancer Research 54(14): 3929-3933
Helfand, B.T.; Xu, J. 2019: Germline testing for prostate cancer prognosis: implications for active surveillance Canadian Journal of Urology 26(5 Suppl 2: 48-49
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Sun, S.-C.; Zhao, H.; Liu, R.; Wang, B.-L.; Liu, Y.-Q.; Zhao, Y.; Shi, Z.-D. 2017: Expression of long non-coding RNA H19 in prostate cancer and its effect on the proliferation and glycometabolism of human prostate cancer cells Zhonghua Nan Ke Xue 23(2): 120-124
Considine, B.; Petrylak, D.P. 2019: Integrating Novel Targets and Precision Medicine into Prostate Cancer Care-Part 1: the Non-Androgen-Targetable Pathways in Castration-Resistant Prostate Cancer Oncology 33(3): 113-118
Grosclaude, P.; Menegoz, F.; Schaffer, P.; Macé Lesec'h, J.; Arveux, P.; Le Mab, G.; Soulié, M.; Villers, A. 1997: Prostate cancer screening (II): is prostate cancer a public health problem? Update of incidence and mortality figures in France from 1982 to 1990 Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(4): 647-654
Ragde, H.; Grado, G.L.; Nadir, B.S. 2001: Brachytherapy for clinically localized prostate cancer: thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Archivos Espanoles de Urologia 54(7): 739-747
Liu, J-he.; Li, H-wei.; Tong, M.; Li, M.; Na, Y-qun. 2004: Genetic risk factors of prostate cancer in Han nationality population in Northern China and a preliminary study of the reason of racial difference in prevalence of prostate cancer Zhonghua Yi Xue Za Zhi 84(5): 364-368
Fourcade, R-Olivier.; Richaud, P.; Coloby, P.; Malavaud, B. 2007: Role of 150 mg bicalutamide in the treatment of prostate cancer: 3rd analysis of the EPC (early prostate cancer) program Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 17(4 Suppl. 1): 891-910
Perrin, P.; François, O.; Maquet, J.H.; Bringeon, G.; Duteil, P.; Devonec, M. 1991: Circulating prostate cancer specific antigens in benign hypertrophy and localized cancer of the prostate Presse Medicale 20(28): 1313-1319
Liu, B.-q.; Wu, Y.-d.; Wei, J.-x.; Zhang, T.; Liu, R.-l.; Ma, T.-x. 2007: Expression of prostate cancer antigen-1 in prostate cancer and its clinical significance Zhonghua Nan Ke Xue 13(11): 997-1001
Ammann, R. 1981: Colonic cancer: early diagnosis with "occult" fecal tests--cancer-crusade between desire and reality Schweizerische Medizinische Wochenschrift 111(20): 694-696